Lensar, a medical device company focused on providing ophthalmic lasers for cataract treatment, installed technology platforms in five private equity-owned ophthalmology groups that allow cataract surgeries to be performed in one-fourth of the time.
5 ophthalmology groups adopt surgery technology, reducing procedure time by 75%
